REVELATION BIOSCIENCES, INC. cotiza a 0.77 USD y tiene una capitalización bursátil de $3M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-li…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.87 | $-2.71 | $-1.65 |
| Estimado | $-0.94 | $-0.83 | $-1.15 | $-3.66 |
| Sorpresa | — | -4.8% | -135.7% | +54.9% |
| Métrica | REVB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -100.6% | -40.4% | -60.2% |
| ROA | -77.0% | -32.0% | -44.9% |
| Current Ratio | 5.41 | 2.84 | +2.57 |
| Debt / Equity | — | 0.28 | — |